Nexi S.p.A.

BST:N0XA Stock Report

Market Cap: €6.7b

Nexi Valuation

Is N0XA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of N0XA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: N0XA (€6.01) is trading below our estimate of fair value (€6.39)

Significantly Below Fair Value: N0XA is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for N0XA?

Key metric: As N0XA is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for N0XA. This is calculated by dividing N0XA's market cap by their current revenue.
What is N0XA's PS Ratio?
PS Ratio1.1x
Sales€6.13b
Market Cap€6.74b

Price to Sales Ratio vs Peers

How does N0XA's PS Ratio compare to its peers?

The above table shows the PS ratio for N0XA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average3.5x
ARLN Aareal Bank
2.3x10.5%€2.0b
DWS DWS Group GmbH KGaA
2x-3.2%€8.0b
HYQ Hypoport
3.3x11.5%€1.4b
PAYTM One97 Communications
6.3x15.7%₹499.1b
N0XA Nexi
1.1x-13.4%€6.7b

Price-To-Sales vs Peers: N0XA is good value based on its Price-To-Sales Ratio (1.1x) compared to the peer average (3.4x).

Price to Sales Ratio vs Industry

How does N0XA's PS Ratio compare vs other companies in the DE Diversified Financial Industry?

3 CompaniesPrice / SalesEstimated GrowthMarket Cap
EBEN aifinyo
0.3xn/aUS$15.51m
EBEN aifinyo
0.2xn/aUS$14.07m
CSQ creditshelf
0.005xn/aUS$29.39k
No more companies available in this PS range
N0XA 1.1xIndustry Avg. 2.0xNo. of Companies3PS01.22.43.64.86+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: N0XA is good value based on its Price-To-Sales Ratio (1.1x) compared to the European Diversified Financial industry average (2x).

Price to Sales Ratio vs Fair Ratio

What is N0XA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

N0XA PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.1x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate N0XA's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst N0XA forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentn/a
€7.88
0%
14.4%€10.40€5.50n/a19
Nov ’25€6.01
€7.93
+32.1%
14.0%€10.40€5.50n/a19
Oct ’25n/a
€8.12
0%
13.9%€10.40€5.50n/a18
Sep ’25n/a
€8.16
0%
13.8%€10.40€5.50n/a18
Aug ’25n/a
€8.08
0%
14.7%€10.40€5.50n/a18
Jul ’25n/a
€8.00
0%
16.3%€10.40€5.50n/a18
Jun ’25n/a
€7.98
0%
15.9%€10.40€5.50n/a19
May ’25n/a
€7.90
0%
16.3%€10.40€5.50n/a19
Apr ’25€5.84
€8.14
+39.4%
15.0%€10.40€5.50n/a19
Mar ’25n/a
€8.67
0%
22.7%€15.80€6.30n/a19
Feb ’25n/a
€8.80
0%
22.6%€15.80€6.30n/a19
Jan ’25n/a
€8.72
0%
22.6%€15.80€6.30n/a19
Dec ’24€7.02
€8.80
+25.4%
22.4%€15.80€6.30n/a19
Nov ’24n/a
€9.21
0%
24.4%€15.80€6.30€6.0119
Oct ’24€5.73
€10.80
+88.4%
18.2%€15.80€7.60n/a18
Sep ’24n/a
€10.98
0%
17.6%€15.80€7.60n/a19
Aug ’24n/a
€11.01
0%
17.8%€15.80€7.60n/a19
Jul ’24n/a
€11.08
0%
17.9%€15.80€7.60n/a18
Jun ’24€7.36
€11.08
+50.6%
17.9%€15.80€7.60n/a18
May ’24n/a
€11.13
0%
17.7%€15.80€7.60n/a18
Apr ’24€7.07
€11.31
+60.1%
15.9%€15.80€8.60€5.8418
Mar ’24n/a
€11.65
0%
14.4%€15.80€8.60n/a18
Feb ’24n/a
€11.62
0%
16.4%€15.80€8.60n/a19
Jan ’24n/a
€12.19
0%
16.0%€15.80€8.60n/a19
Dec ’23n/a
€12.38
0%
14.8%€15.80€9.80€7.0218
Nov ’23€8.77
€12.56
+43.3%
18.8%€18.00€9.60n/a17

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

Yeahka

HK$4.5b

An investment holding company, provides payment and business services to merchants and consumers in the People’s Republic of China.

4YE

HK$1.25

7D

-11.3%

1Y

-29.0%

Exor

€20.3b

Engages in the luxury goods, automotive, agricultural and construction equipment, commercial vehicles, and professional football businesses worldwide.

EYX

€92.90

7D

-2.4%

1Y

7.2%

Merchants Bancorp

US$1.8b

Operates as the diversified bank holding company in the United States.

3KD

US$37.00

7D

-3.1%

1Y

21.7%